NF Bot
@nfbot.bsky.social
NF Bot looking to publish any news, pubmed articles, NF Events, Reddit posts and Bluesky posts.
Please let me know if something doesn't look right.
Please let me know if something doesn't look right.
Thriving Tyneside girl, 11, on the mend after nine surgeries in just four years - Chronicle Live
Thriving Tyneside girl, 11, on the mend after nine surgeries in just four years - Chronicle Live
Thriving Tyneside girl, 11, on the mend after nine surgeries in just four years - Chronicle Live
news.google.com
December 4, 2025 at 11:56 AM
Thriving Tyneside girl, 11, on the mend after nine surgeries in just four years - Chronicle Live
Pasithea Therapeutics Stock Rockets To Best Day In 4 Years On Massive Share Offering Amid ALS Drug Momentum - MSN
Pasithea Therapeutics Stock Rockets To Best Day In 4 Years On Massive Share Offering Amid ALS Drug Momentum - MSN
Pasithea Therapeutics Stock Rockets To Best Day In 4 Years On Massive Share Offering Amid ALS Drug Momentum - MSN
news.google.com
December 4, 2025 at 11:56 AM
Pasithea Therapeutics Stock Rockets To Best Day In 4 Years On Massive Share Offering Amid ALS Drug Momentum - MSN
Pharma Is Sitting on Hidden Cures. Find Your ‘Freda’ To Unlock Them - Yonkers Times
Pharma Is Sitting on Hidden Cures. Find Your ‘Freda’ To Unlock Them - Yonkers Times
Pharma Is Sitting on Hidden Cures. Find Your ‘Freda’ To Unlock Them - Yonkers Times
news.google.com
December 4, 2025 at 11:56 AM
Pharma Is Sitting on Hidden Cures. Find Your ‘Freda’ To Unlock Them - Yonkers Times
Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock - The Globe and Mail
Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock - The Globe and Mail
Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock - The Globe and Mail
news.google.com
December 4, 2025 at 11:56 AM
Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock - The Globe and Mail
Trapped in Silence: Severe Catatonia From Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis in a Neurofibromatosis Type 1 Patient With Craniopharyngioma - Cureus
Trapped in Silence: Severe Catatonia From Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis in a Neurofibromatosis Type 1 Patient With Craniopharyngioma - Cureus
Trapped in Silence: Severe Catatonia From Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis in a Neurofibromatosis Type 1 Patient With Craniopharyngioma - Cureus
news.google.com
December 4, 2025 at 11:56 AM
Trapped in Silence: Severe Catatonia From Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis in a Neurofibromatosis Type 1 Patient With Craniopharyngioma - Cureus
Will Pasithea Therapeutics Deliver On Clinical Promise Or Struggle With Funding Risks? - RTTNews
Will Pasithea Therapeutics Deliver On Clinical Promise Or Struggle With Funding Risks? - RTTNews
Will Pasithea Therapeutics Deliver On Clinical Promise Or Struggle With Funding Risks? - RTTNews
news.google.com
December 4, 2025 at 11:56 AM
Will Pasithea Therapeutics Deliver On Clinical Promise Or Struggle With Funding Risks? - RTTNews
When the Skin Tells a Pulmonary Story: A Case of Neurofibromatosis Type 1-Associated Pulmonary Hypertension - Cureus
When the Skin Tells a Pulmonary Story: A Case of Neurofibromatosis Type 1-Associated Pulmonary Hypertension - Cureus
When the Skin Tells a Pulmonary Story: A Case of Neurofibromatosis Type 1-Associated Pulmonary Hypertension - Cureus
news.google.com
December 4, 2025 at 11:56 AM
When the Skin Tells a Pulmonary Story: A Case of Neurofibromatosis Type 1-Associated Pulmonary Hypertension - Cureus
Quantitative assessment of the corneal subbasal nerve plexus in children with neurofibromatosis type 1 and optic pathway glioma using in vivo confocal microscopy - Nature
Quantitative assessment of the corneal subbasal nerve plexus in children with neurofibromatosis type 1 and optic pathway glioma using in vivo confocal microscopy - Nature
Quantitative assessment of the corneal subbasal nerve plexus in children with neurofibromatosis type 1 and optic pathway glioma using in vivo confocal microscopy - Nature
news.google.com
December 4, 2025 at 11:56 AM
Quantitative assessment of the corneal subbasal nerve plexus in children with neurofibromatosis type 1 and optic pathway glioma using in vivo confocal microscopy - Nature
Thriving Tyneside girl, 11, on the mend after nine surgeries in just four years - Chronicle Live
Thriving Tyneside girl, 11, on the mend after nine surgeries in just four years - Chronicle Live
Thriving Tyneside girl, 11, on the mend after nine surgeries in just four years - Chronicle Live
news.google.com
December 4, 2025 at 10:56 AM
Thriving Tyneside girl, 11, on the mend after nine surgeries in just four years - Chronicle Live
Pharma Is Sitting on Hidden Cures. Find Your ‘Freda’ To Unlock Them - Yonkers Times
Pharma Is Sitting on Hidden Cures. Find Your ‘Freda’ To Unlock Them - Yonkers Times
Pharma Is Sitting on Hidden Cures. Find Your ‘Freda’ To Unlock Them - Yonkers Times
news.google.com
December 4, 2025 at 10:56 AM
Pharma Is Sitting on Hidden Cures. Find Your ‘Freda’ To Unlock Them - Yonkers Times
Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock - The Globe and Mail
Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock - The Globe and Mail
Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock - The Globe and Mail
news.google.com
December 4, 2025 at 10:56 AM
Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock - The Globe and Mail
Trapped in Silence: Severe Catatonia From Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis in a Neurofibromatosis Type 1 Patient With Craniopharyngioma - Cureus
Trapped in Silence: Severe Catatonia From Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis in a Neurofibromatosis Type 1 Patient With Craniopharyngioma - Cureus
Trapped in Silence: Severe Catatonia From Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis in a Neurofibromatosis Type 1 Patient With Craniopharyngioma - Cureus
news.google.com
December 4, 2025 at 10:56 AM
Trapped in Silence: Severe Catatonia From Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis in a Neurofibromatosis Type 1 Patient With Craniopharyngioma - Cureus
Will Pasithea Therapeutics Deliver On Clinical Promise Or Struggle With Funding Risks? - RTTNews
Will Pasithea Therapeutics Deliver On Clinical Promise Or Struggle With Funding Risks? - RTTNews
Will Pasithea Therapeutics Deliver On Clinical Promise Or Struggle With Funding Risks? - RTTNews
news.google.com
December 4, 2025 at 10:56 AM
Will Pasithea Therapeutics Deliver On Clinical Promise Or Struggle With Funding Risks? - RTTNews
Recurrent and Aggressive Solitary Plexiform Neurofibroma with KRAS and AKT1 Alterations: A Case Report - European Medical Journal
Recurrent and Aggressive Solitary Plexiform Neurofibroma with KRAS and AKT1 Alterations: A Case Report - European Medical Journal
Recurrent and Aggressive Solitary Plexiform Neurofibroma with KRAS and AKT1 Alterations: A Case Report - European Medical Journal
news.google.com
December 4, 2025 at 10:56 AM
Recurrent and Aggressive Solitary Plexiform Neurofibroma with KRAS and AKT1 Alterations: A Case Report - European Medical Journal
When the Skin Tells a Pulmonary Story: A Case of Neurofibromatosis Type 1-Associated Pulmonary Hypertension - Cureus
When the Skin Tells a Pulmonary Story: A Case of Neurofibromatosis Type 1-Associated Pulmonary Hypertension - Cureus
When the Skin Tells a Pulmonary Story: A Case of Neurofibromatosis Type 1-Associated Pulmonary Hypertension - Cureus
news.google.com
December 4, 2025 at 10:56 AM
When the Skin Tells a Pulmonary Story: A Case of Neurofibromatosis Type 1-Associated Pulmonary Hypertension - Cureus
Quantitative assessment of the corneal subbasal nerve plexus in children with neurofibromatosis type 1 and optic pathway glioma using in vivo confocal microscopy - Nature
Quantitative assessment of the corneal subbasal nerve plexus in children with neurofibromatosis type 1 and optic pathway glioma using in vivo confocal microscopy - Nature
Quantitative assessment of the corneal subbasal nerve plexus in children with neurofibromatosis type 1 and optic pathway glioma using in vivo confocal microscopy - Nature
news.google.com
December 4, 2025 at 10:56 AM
Quantitative assessment of the corneal subbasal nerve plexus in children with neurofibromatosis type 1 and optic pathway glioma using in vivo confocal microscopy - Nature
Thriving Tyneside girl, 11, on the mend after nine surgeries in just four years - Chronicle Live
Thriving Tyneside girl, 11, on the mend after nine surgeries in just four years - Chronicle Live
Thriving Tyneside girl, 11, on the mend after nine surgeries in just four years - Chronicle Live
news.google.com
December 4, 2025 at 9:56 AM
Thriving Tyneside girl, 11, on the mend after nine surgeries in just four years - Chronicle Live
Pharma Is Sitting on Hidden Cures. Find Your ‘Freda’ To Unlock Them - Yonkers Times
Pharma Is Sitting on Hidden Cures. Find Your ‘Freda’ To Unlock Them - Yonkers Times
Pharma Is Sitting on Hidden Cures. Find Your ‘Freda’ To Unlock Them - Yonkers Times
news.google.com
December 4, 2025 at 9:56 AM
Pharma Is Sitting on Hidden Cures. Find Your ‘Freda’ To Unlock Them - Yonkers Times
Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock - The Globe and Mail
Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock - The Globe and Mail
Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock - The Globe and Mail
news.google.com
December 4, 2025 at 9:56 AM
Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock - The Globe and Mail
Trapped in Silence: Severe Catatonia From Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis in a Neurofibromatosis Type 1 Patient With Craniopharyngioma - Cureus
Trapped in Silence: Severe Catatonia From Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis in a Neurofibromatosis Type 1 Patient With Craniopharyngioma - Cureus
Trapped in Silence: Severe Catatonia From Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis in a Neurofibromatosis Type 1 Patient With Craniopharyngioma - Cureus
news.google.com
December 4, 2025 at 9:56 AM
Trapped in Silence: Severe Catatonia From Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis in a Neurofibromatosis Type 1 Patient With Craniopharyngioma - Cureus
Will Pasithea Therapeutics Deliver On Clinical Promise Or Struggle With Funding Risks? - RTTNews
Will Pasithea Therapeutics Deliver On Clinical Promise Or Struggle With Funding Risks? - RTTNews
Will Pasithea Therapeutics Deliver On Clinical Promise Or Struggle With Funding Risks? - RTTNews
news.google.com
December 4, 2025 at 9:56 AM
Will Pasithea Therapeutics Deliver On Clinical Promise Or Struggle With Funding Risks? - RTTNews
Recurrent and Aggressive Solitary Plexiform Neurofibroma with KRAS and AKT1 Alterations: A Case Report - European Medical Journal
Recurrent and Aggressive Solitary Plexiform Neurofibroma with KRAS and AKT1 Alterations: A Case Report - European Medical Journal
Recurrent and Aggressive Solitary Plexiform Neurofibroma with KRAS and AKT1 Alterations: A Case Report - European Medical Journal
news.google.com
December 4, 2025 at 9:56 AM
Recurrent and Aggressive Solitary Plexiform Neurofibroma with KRAS and AKT1 Alterations: A Case Report - European Medical Journal
Neurofibromatosis Treatment Drugs Market Projections - openPR.com
Neurofibromatosis Treatment Drugs Market Projections - openPR.com
Neurofibromatosis Treatment Drugs Market Projections - openPR.com
news.google.com
December 4, 2025 at 9:56 AM
Neurofibromatosis Treatment Drugs Market Projections - openPR.com
When the Skin Tells a Pulmonary Story: A Case of Neurofibromatosis Type 1-Associated Pulmonary Hypertension - Cureus
When the Skin Tells a Pulmonary Story: A Case of Neurofibromatosis Type 1-Associated Pulmonary Hypertension - Cureus
When the Skin Tells a Pulmonary Story: A Case of Neurofibromatosis Type 1-Associated Pulmonary Hypertension - Cureus
news.google.com
December 4, 2025 at 9:56 AM
When the Skin Tells a Pulmonary Story: A Case of Neurofibromatosis Type 1-Associated Pulmonary Hypertension - Cureus
Quantitative assessment of the corneal subbasal nerve plexus in children with neurofibromatosis type 1 and optic pathway glioma using in vivo confocal microscopy - Nature
Quantitative assessment of the corneal subbasal nerve plexus in children with neurofibromatosis type 1 and optic pathway glioma using in vivo confocal microscopy - Nature
Quantitative assessment of the corneal subbasal nerve plexus in children with neurofibromatosis type 1 and optic pathway glioma using in vivo confocal microscopy - Nature
news.google.com
December 4, 2025 at 9:56 AM
Quantitative assessment of the corneal subbasal nerve plexus in children with neurofibromatosis type 1 and optic pathway glioma using in vivo confocal microscopy - Nature